23 Nov

Change of Directors Interest Notice - Ms Judith Downes

Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/ 0 9/01 Amended 01/01/11 Name of entity : ImpediMed Limited ABN : 089 705 144 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Judith Downes Date of last notice 08 October 20 2 1 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the defin ition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct and Indirect Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. N P Downes Pty Ltd Staff Super annuation Fund Ms Downes is director and member of NP Downes Pty Ltd Staff Superannuation Fund and a beneficiary of the fund. Date of change 18 November 202 1 No. of securities held prior to change Direct: 2 , 121 , 450 Ordinary shares Indirect: 396,484 Ordinary shares Class Ordinary shares Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 2 Number acquired Ind irect: 40,942 Ordinary Shares Number disposed Nil Value/Consideration Note: If consideration is non - cash, provide details and estimated valuation $0. 1 525 per share No. of securities held after change Direct: 2 , 121 , 450 Ordinary shares Indirect: 437 , 426 Ordinary shares Nature of change Example: on - market trade, off - market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy - back Par ti cipation in the share purchase plan. Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non - cash, provide details and an estimated valuation Interest after change Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3 Part 3 – + Closed period Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required? No If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided? Date of Notice: 23 November 20 2 1

More from ImpediMed Limited


Join Listcorp to create a personalised news feed, follow your favourite companies, save useful news, and more.

By joining Listcorp you agree to our Terms & Conditions and Privacy Policy

Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from ImpediMed Limited (ASX:IPD) when you join Listcorp.